Programmable CRISPR-Cas RNA gene circuits for translational theranostics

RNA molecules carry dynamic cellular and pathological information, making them ideal biomarkers for precision medicine. However, conventional RNA diagnosis and therapy operate independently without coordinated signal perception and responsive intervention. RNA-targeting CRISPR-Cas systems, especially Cas13 effectors, enable programmable transcriptome recognition and manipulation without permanent genomic modification. Synthetic CRISPR-based gene circuits integrate RNA sensing, molecular computation and therapeutic execution into one unified platform, bridging the gap between molecular detection and precision treatment. CRISPR-Cas technologies have expanded from programmable RNA recognition and editing tools into increasingly sophisticated platforms for RNA sensing, molecular computation, and therapeutic regulation. This review provides a comprehensive mechanistic and translational synthesis of CRISPR-Cas-based RNA gene circuits, with emphasis on the distinction between individual RNA-targeting components and integrated sensing–computation–actuation architectures. We examine major circuit designs, RNA-responsive logic, therapeutic applications, delivery strategies, circuit-level constraints, safety considerations, and the current experimental and translational evidence. Here, we provide a comprehensive narrative synthesis of the molecular mechanisms, circuit architectures, experimental implementations, delivery strategies, safety considerations, and translational challenges associated with CRISPR-Cas-based RNA gene circuits. By distinguishing component-level technologies from integrated RNA-responsive circuits and separating cell-free, cellular, organoid, animal, and clinical evidence, this review highlights both the capabilities and current limitations of the field. Finally, it outlines future prospects for developing clinically deployable RNA theranostic platforms, emphasizing optimized delivery systems, robust circuit design and rigorous preclinical validation in physiologically relevant disease models.

Authors

Institutions

Publication Details

Journal
Journal of Translational Medicine
Published
2026-11-14
DOI
https://doi.org/10.1186/s12967-026-09215-6
Primary Topic
CRISPR and Genetic Engineering
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Programmable CRISPR-Cas RNA gene circuits for translational theranostics

Fu Wang, Wajahat Ali, Zhenlong Wang, Kulsoom
1 links
Journal of Translational Medicine
CRISPR and Genetic Engineering
article

Programmable CRISPR-Cas RNA gene circuits for translational theranostics

Fu Wang, Wajahat Ali, Zhenlong Wang, Kulsoom
article en

Abstract

RNA molecules carry dynamic cellular and pathological information, making them ideal biomarkers for precision medicine. However, conventional RNA diagnosis and therapy operate independently without coordinated signal perception and responsive intervention. RNA-targeting CRISPR-Cas systems, especially Cas13 effectors, enable programmable transcriptome recognition and manipulation without permanent genomic modification. Synthetic CRISPR-based gene circuits integrate RNA sensing, molecular computation and therapeutic execution into one unified platform, bridging the gap between molecular detection and precision treatment. CRISPR-Cas technologies have expanded from programmable RNA recognition and editing tools into increasingly sophisticated platforms for RNA sensing, molecular computation, and therapeutic regulation. This review provides a comprehensive mechanistic and translational synthesis of CRISPR-Cas-based RNA gene circuits, with emphasis on the distinction between individual RNA-targeting components and integrated sensing–computation–actuation architectures. We examine major circuit designs, RNA-responsive logic, therapeutic applications, delivery strategies, circuit-level constraints, safety considerations, and the current experimental and translational evidence. Here, we provide a comprehensive narrative synthesis of the molecular mechanisms, circuit architectures, experimental implementations, delivery strategies, safety considerations, and translational challenges associated with CRISPR-Cas-based RNA gene circuits. By distinguishing component-level technologies from integrated RNA-responsive circuits and separating cell-free, cellular, organoid, animal, and clinical evidence, this review highlights both the capabilities and current limitations of the field. Finally, it outlines future prospects for developing clinically deployable RNA theranostic platforms, emphasizing optimized delivery systems, robust circuit design and rigorous preclinical validation in physiologically relevant disease models.

Journal of Translational Medicine
Second Affiliated Hospital of Xi'an Jiaotong University (CN), Shaanxi Institute of International Trade & Commerce (CN), Xi'an Jiaotong University (CN)
National Natural Science Foundation of China
CRISPR and Genetic Engineering
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon